Provided by Tiger Trade Technology Pte. Ltd.

Tempus AI

59.01
+0.27000.46%
Post-market: 58.92-0.0900-0.15%19:59 EDT
Volume:3.69M
Turnover:218.66M
Market Cap:10.71B
PE:-41.16
High:60.38
Open:59.47
Low:58.48
Close:58.74
52wk High:104.32
52wk Low:40.77
Shares:181.56M
Float Shares:115.00M
Volume Ratio:0.69
T/O Rate:3.21%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4337
EPS(LYR):-1.4100
ROE:-67.44%
ROA:-8.55%
PB:24.08
PE(LYR):-41.85

Loading ...

Tempus AI to build multimodal whole-genome dataset for AI-driven healthcare

TIPRANKS
·
Sep 11

Tempus AI Launches Effort to Build 100,000 Whole-Genome Dataset Linked to Clinical Outcomes

Reuters
·
Sep 11

Tempus Launches Effort to Build the Largest Multimodal Whole-Genome Dataset to Advance AI-Driven Healthcare Innovation

THOMSON REUTERS
·
Sep 11

Tempus AI, - General Availability of Dataset Planned for Mid-2027

THOMSON REUTERS
·
Sep 11

$1M → $7B ARR In 10Y! Databricks On Enterprise AI Moat

Bellwether Stocks Movement
·
Sep 11

Anthropic: 3 AI Economic Scenarios to 2030, 15% YoY Growth in Bull Case

AI Industry Frontlines
·
Sep 11

HSBC Says The AI Trade's Next Chapter Hinges On One Word: Monetization

Analyst Calls
·
Sep 10

Tempus AI awarded up to $9.5M from ARPA-H for autonomous AI in cardiology

TIPRANKS
·
Sep 10

Tempus AI Wins up to $9.5 Million ARPA-H Advocate Award for Autonomous Heart Failure Agent

Reuters
·
Sep 10

Tempus Secures up to $9.5 Million in Arpa-H Advocate Funding to Deploy First Autonomous AI in Cardiology

THOMSON REUTERS
·
Sep 10

Tempus AI Initiated at Neutral by UBS

Dow Jones
·
Sep 09

UBS Initiates Coverage on Tempus AI With Neutral Rating, $70 Price Target

MT Newswires Live
·
Sep 09

Tempus AI Price Target Announced at $67.00/Share by Roth Capital

Dow Jones
·
Sep 08

Rothschild & Co Redburn Initiates Tempus AI at Neutral With $67 Price Target

MT Newswires Live
·
Sep 08

Arm's Haas: AI Could Cure Cancer In Our Lifetime — If The Industry Can Build Enough Chips

AI Industry Frontlines
·
Sep 08

Kospi Down 27%, Goldman Still Says 12,000: "The Market Is Underpricing This Cycle"

Analyst Calls
·
Sep 07

Tempus AI CEO Lefkofsky to Speak at Morgan Stanley Global Healthcare Conference

Reuters
·
Sep 04

The Cancer Vaccine Gold Rush Has Begun. so Has the Race for Picks and Shovels - Heard on the Street

Dow Jones
·
Sep 04

$15B Credit + $2T Valuation: Anthropic's IPO Ambition

AI Industry Frontlines
·
Sep 04

Goldman Sounds The Alarm: Tokens Fell 29% In A Month — AI's Volume-Up, Price-Down Scissors Is Eroding The Revenue Case For Trillion-Dollar Capex

AI Industry Frontlines
·
Sep 04